美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Relypsa, Inc.

31.99

+0.02000.06%

成交量：107.00

成交額：3,422.93

市值：- -

市盈率：- -

高：32.04

開：31.99

低：31.97

收：31.97

52周最高：32.12

52周最低：10.26

股本：- -

流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Relypsa, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.relypsa.com/

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Relypsa, Inc.(NASDAQ:RLYP)是一家生物製藥公司，專註於在美國從事腎臟、心血管和代謝性疾病治療用非吸收聚合物藥物的開發和商業化。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RLYP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RLYP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLYP\",,,,,undefined,":{"symbol":"RLYP","market":"US","secType":"STK","nameCN":"Relypsa, Inc.","latestPrice":31.99,"timestamp":1472673600000,"preClose":31.97,"halted":0,"volume":107,"delay":0,"changeRate":0.0006255864873318603,"floatShares":0,"shares":0,"eps":0,"marketStatus":"盤後交易","change":0.02,"latestTime":"03-03 18:42:36 EST","open":31.99,"high":32.04,"low":31.97,"amount":3422.93,"amplitude":0.00219,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1772586000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":31.97,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLYP\",,,,,undefined,":{"symbol":"RLYP","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":32.04,"amplitude":0.00219,"preClose":31.97,"low":31.97,"week52Low":10.26,"pbRate":"--","week52High":32.12,"institutionHeld":0,"latestPrice":31.99,"eps":0,"divideRate":0,"volume":107,"delay":0,"open":31.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RLYP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-05-04","symbol":"RLYP","expectedEps":-1.26,"name":"Relypsa, Inc.","time":"盤後","type":"earning","dateTimestamp":1462334400000,"reportTimeType":"post"},{"market":"US","date":"2016-02-24","symbol":"RLYP","expectedEps":-1.32,"name":"Relypsa, Inc.","time":"盤後","type":"earning","dateTimestamp":1456290000000,"reportTimeType":"post","actualEps":-1.4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RLYP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RLYP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.relypsa.com/","compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Relypsa, Inc.(NASDAQ:RLYP)是一家生物製藥公司，專註於在美國從事腎臟、心血管和代謝性疾病治療用非吸收聚合物藥物的開發和商業化。","exchange":"NASDAQ","name":"Relypsa, Inc.","nameEN":"Relypsa, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RLYP\",market:\"US\",,,undefined,":null}}